Publication | Closed Access

Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL

Regenerative MedicineCell TherapyTransplantationMarrow TransplantationMedicineStem Cell TransplantationImmunologyCell BiologyImmunotherapyStem CellsCell TransplantationVivo PurgingGraft RejectionSalvage Therapy